ValiRx plc (AIM:VAL)
London · Delayed Price · Currency is GBP · Price in GBX 0.1885
+0.0035 (1.89%)
Jun 16, 2026, 1:35 PM GMT
ValiRx Market Cap
ValiRx has a market cap or net worth of 1.42 million as of June 16, 2026. Its market cap has decreased by -20.12% in one year.
Market Cap
1.42M
Enterprise Value
468.41K
Revenue
49.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.19
Market Cap Chart
Since October 3, 2006, ValiRx's market cap has decreased from 12.83M to 1.42M, a decrease of -88.93%. That is a compound annual growth rate of -10.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 1.42M | -42.91% |
| Dec 31, 2025 | 2.49M | -14.24% |
| Dec 31, 2024 | 2.90M | -51.94% |
| Dec 29, 2023 | 6.04M | -33.71% |
| Dec 30, 2022 | 9.11M | -61.38% |
| Dec 31, 2021 | 23.58M | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cizzle Biotechnology Holdings | 12.54M |
| Genflow Biosciences | 12.04M |
| Oxford BioDynamics | 7.72M |
| OptiBiotix Health | 6.40M |
| CRISM Therapeutics | 5.69M |
| Nuformix | 5.27M |
| Theracryf | 5.16M |
| Thalia Therapeutics | 4.79M |